Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

C-Rad

21.50 SEK+1.42 %28/10 17:29
Less than 1K followers

CRAD B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+1.42 %
-35.63 %
-42.20 %
-16.67 %
-32.71 %
-36.58 %
-34.85 %
-62.87 %
+65.58 %

C-Rad operates in the medical technology industry and focuses on the development and manufacture of systems for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The business is present on a global level, with a main presence in Europe, North America and Asia. C-Rad was founded in 2004 and is headquartered in Uppsala, Sweden.

Read more
Market cap
725.99M SEK
Turnover
1.66M SEK
Revenue
441.9M
EBIT %
10.21 %
P/E
69.35
Dividend yield-%
0.47 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
11/2
2027

Annual report '26

11/5
2027

Interim report Q1'27

16/7
2027

Interim report Q2'27

Press release2026-10-28 08:00

C-RAD erhåller order värd cirka 8 MSEK och stärker sin närvaro i nordöstra USA

C-Rad
Press release2026-10-28 08:00

C-RAD receives order worth approximately 8 MSEK, strengthening presence in the Northeast U.S.

C-Rad
C-RAD, Audiocast, Q3'26
Webcast2026-10-22 11:00

C-RAD, Audiocast, Q3'26

C-Rad

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-10-22 08:00

C-RAD AB:s Delårsrapport Q3'26

C-Rad
Regulatory press release2026-10-22 08:00

C-RAD's Interim Report Q3’26

C-Rad
Regulatory press release2026-10-22 07:30

C-RAD har beslutat om återköp av egna B-aktier

C-Rad
Regulatory press release2026-10-22 07:30

C-RAD has decided to repurchase own class B shares

C-Rad
Regulatory press release2026-10-15 10:30

C-RADs valberedning inför årsstämman 2027

C-Rad
Press release2026-10-08 08:00

Inbjudan till presentation av C-RADs delårsrapport samt rapport för tredje kvartalet 2026

C-Rad
Press release2026-10-08 08:00

Invitation to presentation of C-RAD’s interim report and report for the third quarter 2026

C-Rad
Regulatory press release2026-09-29 13:00

C-RAD och SeeTreat ingår partnerskap för att gemensamt utveckla individanpassad strålbehandling för varje patient på varje klinik

C-Rad
Regulatory press release2026-09-29 13:00

C-RAD and SeeTreat partner to co-develop personalised radiotherapy for every patient in every clinic

C-Rad
Press release2026-09-28 14:45

C-RAD brings accessible SGRT, expanded interoperability and a first look at the next-generation workflow platform to ASTRO 2026

C-Rad
Press release2026-09-28 14:45

C-RAD deltar på ASTRO 2026 och visar upp lättillgänglig SGRT, utökad interoperabilitet med United Imaging och en första visning av nya produkter för framtidens arbetsflödesplattform

C-Rad
Regulatory press release2026-07-17 08:00

C-RAD AB:s Delårsrapport Q2'26

C-Rad
Regulatory press release2026-07-17 08:00

C-RAD's Interim Report Q2’26

C-Rad
Regulatory press release2026-05-15 09:00

C-RAD och SeeTreat ingår ett partnerskap för att erbjuda mer individanpassad strålbehandling till varje patient

C-Rad
Regulatory press release2026-05-15 09:00

C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient

C-Rad
Press release2026-05-13 09:00

C-RAD markerar sitt nya kapitel på ESTRO 2026 och visar upp klinikdrivna framsteg inom SGRT

C-Rad
Press release2026-05-13 09:00

C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances

C-Rad